tradingkey.logo
tradingkey.logo
Search

Novo Nordisk A/S

NVO
Add to Watchlist
49.165USD
+0.985+2.04%
Market hours ETQuotes delayed by 15 min
165.36BMarket Cap
11.50P/E TTM

NVO Financials

See Novo Nordisk A/S's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Novo Nordisk A/S Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
--/0.76
Revenue / Forecast
--/10.95B
Period
FY2025 Earnings
Revenue(YoY)
46.70B
10.88%
EPS(YoY)
3.48
5.93%
Analyst Rating
HOLD
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
85.74%1.71
4.03%0.94
-21.92%0.71
39.57%0.91
11.02%0.92
26.73%0.91
23.23%0.90
2.66%0.65
30.83%0.83
74.89%0.72
--0.73
--0.63
--0.63
--0.41
--1.32
----
----
----
----
----
Revenue
37.80%15.17B
0.69%12.34B
11.81%11.74B
18.85%11.67B
15.63%11.01B
28.92%12.25B
22.51%10.50B
23.78%9.82B
23.77%9.52B
44.11%9.50B
38.88%8.57B
34.20%7.94B
21.33%7.69B
11.89%6.60B
9.31%6.17B
10.52%5.91B
15.66%6.34B
14.50%5.89B
16.39%5.65B
20.79%5.35B
Net Profit
85.87%7.61B
3.84%4.19B
-22.07%3.13B
39.12%4.03B
10.58%4.09B
27.38%4.04B
22.55%4.02B
1.91%2.89B
29.61%3.70B
70.04%3.17B
68.13%3.28B
48.77%2.84B
33.25%2.86B
11.29%1.86B
1.57%1.95B
-2.78%1.91B
4.71%2.14B
12.21%1.67B
18.91%1.92B
25.16%1.96B
Net Margin
34.88%50.15%
3.13%33.98%
-30.30%26.68%
17.05%34.48%
-4.37%37.18%
-1.20%32.95%
0.03%38.28%
-17.66%29.46%
4.72%38.88%
17.99%33.35%
--38.27%
--35.78%
--37.13%
--28.26%
--32.54%
----
----
----
----
----
Gross Margin
2.95%85.96%
-4.65%80.86%
-9.53%76.12%
-1.91%83.29%
-1.57%83.49%
0.00%84.80%
0.82%84.14%
-0.73%84.90%
0.19%84.83%
2.39%84.80%
--83.46%
--85.53%
--84.67%
--82.82%
--84.34%
----
----
----
----
----
Debt to assets ratio
7.85%26.18%
9.31%24.12%
37.83%19.76%
33.28%20.59%
169.42%24.27%
156.97%22.07%
62.11%14.33%
68.72%15.45%
-11.74%9.01%
-19.65%8.59%
--8.84%
--9.16%
--10.21%
--10.69%
--10.69%
----
----
----
----
----
Revenue
37.80%15.17B
0.69%12.34B
11.81%11.74B
18.85%11.67B
15.63%11.01B
28.92%12.25B
22.51%10.50B
23.78%9.82B
23.77%9.52B
44.11%9.50B
38.88%8.57B
34.20%7.94B
21.33%7.69B
11.89%6.60B
9.31%6.17B
10.52%5.91B
15.66%6.34B
14.50%5.89B
16.39%5.65B
20.79%5.35B
Operating profit
70.80%9.34B
-3.92%5.05B
4.31%5.20B
13.40%5.18B
17.87%5.47B
36.02%5.25B
26.80%4.98B
30.77%4.57B
28.72%4.64B
64.83%3.86B
43.67%3.93B
32.47%3.49B
24.81%3.60B
11.77%2.34B
13.11%2.73B
10.12%2.64B
18.88%2.89B
17.08%2.10B
20.30%2.42B
17.15%2.39B
Net Profit
85.87%7.61B
3.84%4.19B
-22.07%3.13B
39.12%4.03B
10.58%4.09B
27.38%4.04B
22.55%4.02B
1.91%2.89B
29.61%3.70B
70.04%3.17B
68.13%3.28B
48.77%2.84B
33.25%2.86B
11.29%1.86B
1.57%1.95B
-2.78%1.91B
4.71%2.14B
12.21%1.67B
18.91%1.92B
25.16%1.96B
Current assets
8.45%27.42B
21.40%27.12B
-1.93%28.59B
0.80%25.71B
50.08%25.29B
8.05%22.34B
44.58%29.15B
26.48%25.50B
1.59%16.85B
32.75%20.68B
27.99%20.16B
38.88%20.16B
28.81%16.58B
19.01%15.57B
10.94%15.75B
18.02%14.52B
32.95%12.88B
21.15%13.09B
22.44%14.20B
10.89%12.30B
Total current liabilities
1.72%34.82B
12.29%33.92B
18.36%36.84B
21.45%32.79B
42.85%34.24B
20.24%30.20B
27.20%31.13B
17.60%27.00B
24.78%23.97B
44.28%25.12B
42.46%24.47B
48.50%22.96B
35.03%19.21B
14.42%17.41B
24.89%17.18B
33.18%15.46B
24.57%14.22B
31.91%15.22B
23.11%13.75B
14.44%11.61B
Total assets
21.94%86.49B
32.02%85.38B
35.64%80.53B
43.54%76.18B
63.95%70.92B
38.90%64.67B
39.51%59.37B
28.96%53.07B
18.87%43.26B
34.07%46.56B
32.90%42.56B
33.33%41.15B
24.07%36.39B
16.78%34.73B
18.13%32.02B
22.44%30.87B
31.51%29.33B
25.02%29.74B
23.01%27.10B
22.84%25.21B
Total liabilities
8.35%55.08B
22.59%54.86B
30.11%53.82B
34.47%49.63B
75.64%50.84B
45.37%44.75B
40.85%41.37B
32.31%36.91B
16.88%28.95B
35.55%30.78B
34.05%29.37B
36.94%27.89B
27.47%24.77B
20.03%22.71B
30.33%21.91B
38.04%20.37B
48.59%19.43B
41.28%18.92B
32.84%16.81B
28.67%14.76B
Total equity
56.35%31.41B
53.18%30.52B
48.34%26.71B
64.25%26.56B
40.33%20.09B
26.28%19.92B
36.53%18.00B
21.90%16.17B
23.13%14.31B
31.28%15.78B
30.42%13.19B
26.35%13.26B
17.41%11.63B
11.11%12.02B
-1.77%10.11B
0.41%10.50B
7.30%9.90B
4.06%10.82B
9.74%10.29B
15.46%10.45B
Net operating income
5.78%3.67B
-32.48%1.19B
11.81%7.22B
-15.00%6.19B
66.24%3.47B
27.63%1.76B
8.00%6.46B
74.52%7.29B
-51.47%2.09B
41.53%1.38B
82.10%5.98B
21.63%4.18B
20.79%4.30B
309.90%973.84M
-3.69%3.28B
-16.04%3.43B
94.93%3.56B
-1783.79%-463.95M
24.14%3.41B
14.19%4.09B
Net investment
-99.43%-1.88B
48.84%-6.67B
21.53%-2.42B
27.67%-2.16B
-263.22%-940.65M
-514.22%-13.05B
-59.27%-3.08B
-120.49%-2.99B
160.16%576.30M
-11.81%-2.12B
-187.62%-1.93B
-125.46%-1.36B
-233.08%-958.00M
40.05%-1.90B
8.54%-672.14M
-28.79%-601.82M
49.04%-287.62M
-53.31%-3.17B
22.75%-734.88M
-131.59%-467.30M
Net financing
-436.25%-2.58B
-12.79%4.59B
1.20%-2.68B
-391.65%-7.02B
119.99%768.39M
460.85%5.27B
6.38%-2.71B
230.87%2.41B
-29.32%-3.84B
-38.82%-1.46B
-46.73%-2.90B
-23.08%-1.84B
-2.98%-2.97B
-250.33%-1.05B
-6.08%-1.97B
-140.64%-1.49B
-22.97%-2.89B
1312.98%699.54M
-10.85%-1.86B
45.22%-621.12M

FAQs

What is the total revenue of Novo Nordisk A/S?

According to Novo Nordisk A/S's FY2025 earnings report, its total revenue reached 46.70B, with a year-on-year change of 42.12B.

What are the current assets of Novo Nordisk A/S?

According to Novo Nordisk A/S's FY2025 earnings report, its current assets were 27.12B, with a year-on-year change of 21.40.

What are the total assets of Novo Nordisk A/S?

According to Novo Nordisk A/S's FY2025 earnings report, its total assets of Novo Nordisk A/S were 85.38B, with a year-on-year change of 32.02.

What are the total liabilities of Novo Nordisk A/S?

According to Novo Nordisk A/S's FY2025 earnings report, its total liabilities of Novo Nordisk A/S were 54.86B, with a year-on-year change of 22.59.

What is the total equity of Novo Nordisk A/S?

According to Novo Nordisk A/S's FY2025 earnings report, its total equity of Novo Nordisk A/S was 30.52B, with a year-on-year change of 53.18.

What is the net operating income of Novo Nordisk A/S?

According to Novo Nordisk A/S's FY2025 earnings report, its net operating income of Novo Nordisk A/S was 21.61B, with a year-on-year change of 7.25.

What is the net investment of Novo Nordisk A/S?

According to Novo Nordisk A/S's FY2025 earnings report, its net investment of Novo Nordisk A/S was -11.96B, with a year-on-year change of 36.02.

What is the net financing of Novo Nordisk A/S?

According to Novo Nordisk A/S's FY2025 earnings report, its net financing of Novo Nordisk A/S was -4.29B, with a year-on-year change of -438.82.

What is the Earnings Per Share (EPS) of Novo Nordisk A/S?

According to Novo Nordisk A/S's FY2025 earnings report, its Earnings Per Share (EPS) was 3.48, with a year-on-year change of 5.93.

What is the net income of Novo Nordisk A/S?

According to Novo Nordisk A/S's FY2025 earnings report, its net income was 15.48B, with a year-on-year change of 5.67.

What is the net margin of Novo Nordisk A/S?

According to Novo Nordisk A/S's FY2025 earnings report, its net profit margin was 33.14, with a year-on-year change of -4.69.

What is the gross margin of Novo Nordisk A/S?

According to Novo Nordisk A/S's FY2025 earnings report, its gross margin was 82.51, with a year-on-year change of -2.83.

What is the debt-to-asset ratio of Novo Nordisk A/S?

According to Novo Nordisk A/S's FY2025 earnings report, its debt-to-asset ratio was 24.12, with a year-on-year change of 9.31.

What is the Return on Equity (ROE) of Novo Nordisk A/S?

According to Novo Nordisk A/S's FY2025 earnings report, its Return on Equity (ROE) was 61.38, with a year-on-year change of -25.21.

What is the Return on Assets (ROA) of Novo Nordisk A/S?

According to Novo Nordisk A/S's FY2025 earnings report, its Return on Assets (ROA) was 20.63, with a year-on-year change of -21.66.

What is the operating profit of Novo Nordisk A/S?

According to Novo Nordisk A/S's FY2025 earnings report, its operating profit was 21.61B, with a year-on-year change of 7.25.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.